by Michael Laidlaw, MD
Michael Laidlaw is a physician board certified in Endocrinology, Diabetes and Metabolism and Internal Medicine. Research interests have included circadian rhythms, magnesium and bone disorders, thyroid carcinoma, type 2 diabetes education, weight loss and food addiction. He has been active in private practice for 12 years. Most recently he has been involved in education regarding male and female sex hormones and development including critically examining childhood gender dysphoria diagnosis and treatment from the perspective of an endocrinologist. You can read more here, and see his testimony to the California Senate regarding foster children and gender affirmative care here.
Find him on Twitter @MLaidlawMD
The New York Times article “Helping Pediatricians Care for Transgender Children” pitches the American Academy of Pediatrics policy paper on comprehensive care for transgender adolescents [1,2]. This care includes the most radical and risky of hormone manipulations and surgeries. There is a concept defined called “gender identity” which has no physical presence and apparently can only be made known to the person in which it resides. Comprehensive gender affirmative therapy is a high risk, experimental therapy based on low quality evidence and represents a treatment for a condition which cannot be diagnosed by any doctor.
Consider, if you were told your child had cancer would you expect to see that a tissue sample had been collected and analyzed to prove the diagnosis? If you were told that your child has diabetes would you expect to see blood sugar results that confirm the diagnosis?….
Read more HERE.